Detalhe da pesquisa
1.
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.
Clin Cancer Res
; 29(1): 60-66, 2023 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36255372
2.
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts.
Elife
; 82019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31663852